Healthcare >> CEO Interviews >> May 6, 2002
BRADLEY G. THOMPSON is Chairman, President and Chief Executive
Officer of Oncolytics Biotech, Inc. Dr. Thompson has provided
leadership to various organizations within the biotechnology
sector for almost 20 years. Prior to his role with Oncolytics, he
held a number of senior executive positions with SYNSORB Biotech
from 1994 to 1999. From 1983 to 1994, Dr. Thompson worked in a
senior role at The Alberta Research Council. Dr. Thompson sits on
the Boards of four publicly traded companies. He received his PhD
from the University of Western Ontario in the Department of
Microbiology and Immunology. Profile
company and an overview of what you're doing at the present time?
Dr. Thompson: Oncolytics Biotech is focused on the development
